2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
Biotech stocks like Viking Therapeutics offer promising candidates for potential game-changing treatments. With exciting research and upcoming milestones, investors can benefit from positive news and growth in product revenue. Viking's weight loss drug shows strong potential, with forecasts of over 200% gains in the next year.